These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8991348)

  • 1. Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
    Sahibzada NJ; Tareen AK; Khursheed T; Darr N
    J Pak Med Assoc; 1996 Mar; 46(3):53-5. PubMed ID: 8991348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
    Iraji F; Sadeghinia A
    Ann Trop Med Parasitol; 2005 Jan; 99(1):3-9. PubMed ID: 15701249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cutaneous leishmaniasis by photodynamic therapy.
    Gardlo K; Horska Z; Enk CD; Rauch L; Megahed M; Ruzicka T; Fritsch C
    J Am Acad Dermatol; 2003 Jun; 48(6):893-6. PubMed ID: 12789181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
    Asilian A; Davami M
    Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.
    Asilian A; Jalayer T; Nilforooshzadeh M; Ghassemi RL; Peto R; Wayling S; Olliaro P; Modabber F
    Bull World Health Organ; 2003; 81(5):353-9. PubMed ID: 12856053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.
    Ozgoztasi O; Baydar I
    Int J Dermatol; 1997 Jan; 36(1):61-3. PubMed ID: 9071622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
    Neal RA; Murphy AG; Olliaro P; Croft SL
    Trans R Soc Trop Med Hyg; 1994; 88(2):223-5. PubMed ID: 8036682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
    Ben Salah A; Ben Messaoud N; Guedri E; Zaatour A; Ben Alaya N; Bettaieb J; Gharbi A; Belhadj Hamida N; Boukthir A; Chlif S; Abdelhamid K; El Ahmadi Z; Louzir H; Mokni M; Morizot G; Buffet P; Smith PL; Kopydlowski KM; Kreishman-Deitrick M; Smith KS; Nielsen CJ; Ullman DR; Norwood JA; Thorne GD; McCarthy WF; Adams RC; Rice RM; Tang D; Berman J; Ransom J; Magill AJ; Grogl M
    N Engl J Med; 2013 Feb; 368(6):524-32. PubMed ID: 23388004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
    Asilian A; Jalayer T; Whitworth JA; Ghasemi RL; Nilforooshzadeh M; Olliaro P
    Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J
    J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B; Abbaszadeh B; Khamesipour A
    Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
    Arana BA; Mendoza CE; Rizzo NR; Kroeger A
    Am J Trop Med Hyg; 2001 Nov; 65(5):466-70. PubMed ID: 11716099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.
    Ben Salah A; Zakraoui H; Zaatour A; Ftaiti A; Zaafouri B; Garraoui A; Olliaro PL; Dellagi K; Ben Ismail R
    Am J Trop Med Hyg; 1995 Aug; 53(2):162-6. PubMed ID: 7677218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Topical treatment of persistent cutaneous leishmaniasis with paromomycin].
    Flaig MJ; Rupec J; Ruzicka T; Rupec RA
    Hautarzt; 2007 Aug; 58(8):689-90, 692. PubMed ID: 17676349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
    J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of 'Old World' cutaneous leishmaniasis with aminosidine ointment: results of an open study in London.
    Bryceson AD; Murphy A; Moody AH
    Trans R Soc Trop Med Hyg; 1994; 88(2):226-8. PubMed ID: 8036683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M; Schuster BG; Ellis WY; Berman JD
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
    el-On J; Halevy S; Grunwald MH; Weinrauch L
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):227-31. PubMed ID: 1430361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.